Celldex Therapeutics Stock News & Updates
[WKN: A2PEAB | Symbol: CLDX]
Analysts' Top 5 Price Targets of April 20, 2026
Intuit [US4612021034] Jefferies confirms Buy rating with a price target of $ 650 (66% upside potential)...
Celldex Therapeutics (CLDX): Canaccord Sees Nearly 200% Price Potential for the Stock!
Celldex Therapeutics (CLDX) has established itself as an innovative biopharmaceutical company in the...
- ‹
- 1
- ›